FPH News & Analysis

Fisher & Paykel Healthcare (FPH) Reports Strong H2 2026 Results

Fisher & Paykel Healthcare (FPH) announced its financial results for the second half of 2026, reporting a 12% increase in revenue to NZD 485 million. The company's net profit after tax was NZD 120 million, marking a 10% year-on-year growth. These results indicate strong demand in the healthcare sector and could positively impact the company’s stock performance. The company's P/E ratio currently stands at 25, reflecting investor confidence in sustained growth.